Scalora, Nicholas
DeWane, Gillian
Drebot, Yuliia
Khan, Ali A.
Sinha, Souradip
Ghosh, Krishnendu
Robinson, Denise
Cogswell, Patricia
Bellizzi, Andrew M.
Snow, Anthony N.
Breheny, Patrick
Chimenti, Michael S.
Tanas, Munir R.
Funding for this research was provided by:
EHE Foundation (Predoctoral fellowship)
National Institutes of Health, National Cancer Institute (1 R01 CA237031-01A1)
Veterans Health Administration Merit Review Program (1 I01 BX003644-01)
Article History
Received: 27 April 2025
Accepted: 9 September 2025
First Online: 10 October 2025
Declarations
:
: Munir Tanas serves as a consultant for Vivace Therapeutics (San Mateo, CA). There are no other conflicts of interest to report. All the remaining authors declare no conflict of interest.